Nabla is building a drug discovery platform focused on therapeutic antibodies. Founded by pioneers in the field of protein language modeling, Nabla’s cutting-edge AI can predict a protein’s “developability” from only its sequence and their synthetic biology platform can engineer antibodies with functional characteristics, not seen in nature.